Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Orthop Nurs ; 42(4): 230-242, 2023.
Article in English | MEDLINE | ID: mdl-37494903

ABSTRACT

A randomized clinical trial was conducted over a threemonth period with 102 participants undergoing a total hip arthroplasty (THA) or total knee arthroplasty (TKA). The study purpose was to assess whether there was a reduction in the use of opioids in the postoperative period for THA or TKA participants that utilized lavender aromatherapy as an adjunct to pain medication. The participants in the control and intervention group were administered nonopioid pain medication around the clock and opioids as needed after surgery. However, the intervention group also received a pre-packaged lavender essential oil inhaler. Total oral morphine equivalents (OME) were calculated for each participant to determine opioid usage. Although the total OME was similar for the groups overall, the total OME was slightly lower for THA patients that were enrolled in the intervention group (median 22.5) compared to THA patients that were enrolled in the control group (median 31.2). In the intervention group, 58% of participants reported that the lavender inhaler was a useful tool for pain management and 76% indicated they would continue to use the lavender inhaler after discharge.


Subject(s)
Aromatherapy , Arthroplasty, Replacement, Hip , Arthroplasty, Replacement, Knee , Lavandula , Humans , Arthroplasty, Replacement, Knee/adverse effects , Pain, Postoperative/drug therapy , Analgesics, Opioid/therapeutic use , Arthroplasty, Replacement, Hip/adverse effects
2.
Home Healthc Now ; 40(4): 229, 2022.
Article in English | MEDLINE | ID: mdl-35777948

Subject(s)
Hospice Care , Hospices , Humans
3.
Home Healthc Now ; 40(3): 173, 2022.
Article in English | MEDLINE | ID: mdl-35510976

Subject(s)
Hospice Care , Hospices , Humans
4.
Am J Physiol Cell Physiol ; 288(3): C659-68, 2005 Mar.
Article in English | MEDLINE | ID: mdl-15509661

ABSTRACT

Microvascular endothelial cells embedded within three-dimensional (3D) type I collagen matrixes assemble into cellular networks, a process that requires the upregulation of membrane type 1 (MT1) matrix metalloproteinase (MMP) and MMP-2. The purpose of this study was to identify the signaling pathways responsible for the transcriptional activation of MT1-MMP and MMP-2 in endothelial cells in 3D collagen lattices. We hypothesized that the 3D type I collagen induction of MT1-MMP and MMP-2 is mediated by the mitogen-activated protein kinase family of enzymes. Here, we show that 3D type I collagen elicits a persistent increase in ERK1/2 and JNK activation and a decrease in p38 activation. Inhibition of ERK1/2 or JNK disrupted endothelial network formation in 3D type I collagen lattices, whereas inhibition of p38 promoted network formation. mRNA levels of both MT1-MMP and MMP-2 were attenuated by ERK1/2 inhibition but unaffected by either JNK or p38 inhibition. By contrast, expression of constitutively active MEK was sufficient to stimulate MMP-2 production in a monolayer of endothelial cells cultured on type I collagen. These results provide evidence that signaling through both ERK1/2 and JNK regulates endothelial assembly into cellular networks but that the ERK1/2 signaling cascade specifically regulates network formation and the production of both MT1-MMP and MMP-2 genes in response to 3D type I collagen.


Subject(s)
Endothelial Cells/cytology , Endothelial Cells/metabolism , MAP Kinase Signaling System/physiology , Matrix Metalloproteinase 2/metabolism , Metalloendopeptidases/metabolism , Animals , Cell Culture Techniques/methods , Cells, Cultured , Collagen Type I/metabolism , DNA-Binding Proteins/metabolism , Early Growth Response Protein 1 , Enzyme Activation , Extracellular Signal-Regulated MAP Kinases/antagonists & inhibitors , Extracellular Signal-Regulated MAP Kinases/metabolism , Immediate-Early Proteins/metabolism , JNK Mitogen-Activated Protein Kinases/antagonists & inhibitors , JNK Mitogen-Activated Protein Kinases/metabolism , MAP Kinase Kinase Kinases/antagonists & inhibitors , MAP Kinase Kinase Kinases/metabolism , Matrix Metalloproteinase 2/genetics , Matrix Metalloproteinases, Membrane-Associated , Metalloendopeptidases/genetics , Rats , Transcription Factors/metabolism , Transcriptional Activation , p38 Mitogen-Activated Protein Kinases/antagonists & inhibitors , p38 Mitogen-Activated Protein Kinases/metabolism
5.
J Biol Chem ; 278(48): 47785-91, 2003 Nov 28.
Article in English | MEDLINE | ID: mdl-14512418

ABSTRACT

Matrix metalloproteinase-2 (MMP-2) plays a critical role in endothelial cells during the processes of angiogenesis and vascular remodeling. Endothelial cell production of MMP-2 is greatly enhanced when cells are cultured within a three-dimensional type I collagen matrix coinciding with the increased invasive and migratory phenotype of the cells. To define the transcriptional regulation of MMP-2 in rat microvascular endothelial cells, we performed promoter-reporter assays with a series of promoter truncations. Activity of the full promoter was significantly greater in cells cultured within three-dimensional type I collagen compared with cells cultured as a monolayer (two-dimensional) on type I collagen. Truncation of the region encompassing base pairs -1562 to -1375 (relative to the start codon) of the MMP-2 promoter resulted in loss of this differential activity of the MMP-2 promoter. Analysis of this region indicated two putative GATA-2 binding domains between -1437 and -1387. Southwestern blot analysis and electrophoretic mobility shift assays confirmed the binding of GATA-2 to this region of the MMP-2 promoter. Overexpression of GATA-2 in COS-7 cells significantly increased the activity of the full-length MMP-2 promoter-luciferase construct. Endothelial cells expressed greater levels of GATA-2 protein in three-dimensional compared with two-dimensional cultures, and activity of the -1437/-1387 region of the MMP-2 promoter was significantly greater in three-dimensional cultured endothelial cells. Together, these results indicate GATA-2 regulation of the MMP-2 promoter in endothelial cells and that the GATA-2 binding domain is sufficient to drive increased activity of the MMP-2 promoter in response to an extracellular matrix stimulus.


Subject(s)
DNA-Binding Proteins/metabolism , Endothelial Cells/enzymology , Endothelial Cells/metabolism , Matrix Metalloproteinase 2/biosynthesis , Transcription Factors/metabolism , Up-Regulation , Animals , Base Sequence , Blotting, Northern , Blotting, Western , COS Cells , Cell Nucleus/metabolism , Cells, Cultured , Collagen/metabolism , Extracellular Matrix/metabolism , GATA2 Transcription Factor , Gelatin/pharmacology , Genes, Reporter , Luciferases/metabolism , Matrix Metalloproteinase 2/metabolism , Microcirculation/metabolism , Molecular Sequence Data , Neovascularization, Physiologic , Phenotype , Promoter Regions, Genetic , Protein Binding , Rats , Transcription, Genetic , Transcriptional Activation , Transfection
6.
Am J Physiol Heart Circ Physiol ; 283(4): H1430-8, 2002 Oct.
Article in English | MEDLINE | ID: mdl-12234794

ABSTRACT

Capillary growth in skeletal muscle occurs via the dissimilar processes of abluminal sprouting or longitudinal splitting, which can be initiated by muscle stretch and elevated shear stress, respectively. The distinct morphological hallmarks of these types of capillary growth suggest that discrete sets of angiogenic mediators play a role in each situation. Because proteolysis and proliferation are two key steps associated with capillary growth, we tested whether differences in the regulation of matrix metalloproteinases (MMPs) or VEGF may be associated with the two types of capillary growth. We found significant increases in MMP-2 total protein and percent activation, and membrane type-1 MMP mRNA levels, compared with controls after muscle stretch but not after shear stress stimulation. In contrast, VEGF protein and endothelial cell proliferation increased after either angiogenic stimulus. We observed that MMP-2 regulation occurs independent of VEGF signaling, because VEGF did not induce MMP-2 production or activation in isolated endothelial cells. Our data suggest that the involvement of MMPs in capillary growth is dependent on the nature of the angiogenic stimulus.


Subject(s)
Endothelial Growth Factors/metabolism , Lymphokines/metabolism , Matrix Metalloproteinase 2/metabolism , Muscle Contraction/physiology , Muscle, Skeletal/physiology , Neovascularization, Physiologic/physiology , Animals , Antihypertensive Agents/pharmacology , Capillaries/drug effects , Capillaries/physiology , Cells, Cultured , Male , Matrix Metalloproteinases, Membrane-Associated , Metalloendopeptidases/genetics , Muscle Fibers, Skeletal/cytology , Muscle Fibers, Skeletal/enzymology , Muscle, Skeletal/blood supply , Prazosin/pharmacology , RNA, Messenger/analysis , Rats , Rats, Sprague-Dawley , Stress, Mechanical , Vascular Endothelial Growth Factor A , Vascular Endothelial Growth Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...